CN Stock MarketDetailed Quotes

600201 Jinyu Bio-Technology

Watchlist
  • 6.98
  • 0.000.00%
Not Open Apr 25 09:30 CST
7.82BMarket Cap98.31P/E (TTM)

About Jinyu Bio-Technology Company

公司系1992年12月经呼和浩特市体改委以呼体改宏字(1992)4号文批准设立,发起人为呼和浩特市金属材料公司、包头钢铁稀土公司、呼和浩特市立鑫实业开发公司和呼和浩特市租赁公司,以原呼和浩特市金属材料公司为主体改组设立,1999年1月在上海证券交易所上市。公司主要从事兽用生物制品的研发、生产与销售。公司主要产品:猪用疫苗、反刍动物疫苗、禽用疫苗、宠物类疫苗。企业荣誉:公司荣获“2019中国上市公司金质量奖”、“2019蛋鸡产业替抗突出贡献奖”荣誉称号;金宇保灵荣获“医药工业百强企业”、“内蒙古自治区绿色制造工厂示范项目”,公司领导和员工分别荣获“上海证券报社金质量卓越企业家奖”、“全国五一劳动奖章”、内蒙古自治区“五一劳动奖章”、呼和浩特市“五一劳动奖章”、“北疆工匠”等称号。

Company Profile

Short Name-A生物股份
Symbol-A600201
Company NameJinyu Bio-Technology Co., Ltd.
Listing DateJan 15, 1999
Issue Price6.83
Shares Offered35.00M share(s)
FoundedMar 13, 1993
Listed ExchangeSH Stock Exchange
Legal Representativechongyu zhang
General Managerjing zhang
Secretarymin peng
Accounting Firm致同会计师事务所(特殊普通合伙)
Securities Representativeyikun liu
Legal Counsel内蒙古建中律师事务所
Employees26
Phone0471-6539434
Office Address内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号
Zip Code010111
Registered Address内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号
Fax0471-8086060
Emailstock@jinyu.com.cn
Business License150000000005047
Business兽用生物药品制造和销售;兽用化学药品制剂制造和销售;化学试剂和助剂制造和销售;生物药品制剂制造和销售;生物技术开发、转让、咨询服务;先进医疗设备及器械制造和销售;货物进出口、技术进出口;物业管理。(依法须经批准的项目,经相关部门批准后方可开展经营活动)

Company Executives

  • Name
  • Position
  • Salary
  • chongyu zhang
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 1.30M
  • jing zhang
  • Vice Chairman, Directors, President, Strategy Committee Member
  • 1.19M
  • min peng
  • Directors, Board Secretary, Chief Financial Officer, Strategy Committee Member
  • 1.19M
  • zhenping wu
  • Independent Directors, Audit Committee Member, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members
  • 136.80K
  • guihong zhang
  • Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee
  • 136.80K
  • change shen
  • Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 136.80K
  • ming geng
  • Independent Directors
  • 124.50K
  • yikun liu
  • Securities Affairs Representative
  • --
  • renmei dong
  • Chairman of the Supervisory Board, Auditors
  • 440.30K
  • ning li
  • Auditors
  • 453.90K
  • rong li
  • VP
  • 665.00K
  • jiulian chen
  • Employee Supervisors
  • 215.30K
  • riming gao
  • Employee Directors, Audit Committee Member
  • 810.70K

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More